Literature DB >> 6803081

Use of polyamine antimetabolites in experimental tumours and in human leukemia.

J Jänne, L Alhonen-Hongisto, P Seppänen, M Siimes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6803081

Source DB:  PubMed          Journal:  Med Biol        ISSN： 0302-2137


× No keyword cloud information.
  11 in total

Review 1.  The chemotherapeutic potential of polyamine antimetabolites.

Authors:  A N Kingsnorth
Journal:  Ann R Coll Surg Engl       Date:  1986-03       Impact factor: 1.891

2.  Inhibition of S-adenosylmethionine decarboxylase and diamine oxidase activities by analogues of methylglyoxal bis(guanylhydrazone) and their cellular uptake during lymphocyte activation.

Authors:  J Jänne; D R Morris
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

3.  Sequential inhibition of polyamine synthesis. A phase I trial of DFMO (alpha-difluoromethylornithine) and methyl-GAG [methylglyoxal-bis(guanylhydrazone)].

Authors:  R P Warrell; C J Coonley; J H Burchenal
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Polyamine biosynthesis is required for the maintenance of peripheral blood cell elements in the rat.

Authors:  G D Luk; S J Sharkis; M D Abeloff; P P McCann; A Sjoerdsma; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

5.  Amine-specificity of the inactivating ornithine decarboxylase modification in Physarum polycephalum.

Authors:  J L Mitchell; G K Mitchell; D D Carter
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

6.  Carnitine prevents the early mitochondrial damage induced by methylglyoxal bis(guanylhydrazone) in L1210 leukaemia cells.

Authors:  P Nikula; H Ruohola; L Alhonen-Hongisto; J Jänne
Journal:  Biochem J       Date:  1985-06-01       Impact factor: 3.857

7.  Failure of ornithine decarboxylase inhibition to alter small intestinal epithelial repair after transient segmental ischaemia.

Authors:  C Guzman; R J MacLeod; J R Hamilton
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

8.  Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis.

Authors:  A B Clarkson; C J Bacchi; G H Mellow; H C Nathan; P P McCann; A Sjoerdsma
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Polyamines and estrogen control of growth of the NMU-induced rat mammary tumor.

Authors:  A Manni; C Wright; M Pontari
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

10.  Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine (alpha difluoromethylornithine) and methylglyoxal-bis-guanyl hydrazone (methyl-GAG).

Authors:  J A Gastaut; G Tell; P J Schechter; D Maraninchi; B Mascret; Y Carcassonne
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.